Obesity has grown to a full-scale epidemic over the last 40 years. The latest innovation in weight management is the GLP-1 drug class. Originally developed for diabetes, these medications have become synonymous with weight loss. Unfortunately, they are also synonymous with high cost.

As the pressure to make a coverage decision mounts for those responsible for pharmacy benefits, leaders need clear answers that cut through the opinions and noise. Watch the pharmacist-led webinar at your convenience.

Our pharmacists discuss GLP-1s, analyze potential pharmacy benefit strategies, and evaluate potential member and plan impact.

Highlights:

• Examine the research on clinical impacts, discuss emerging concerns and explore the pharmaceutical pipeline
• Walk away with a better understanding of the cost to cover the drug for weight loss and a recommended course of action.

Watch the webinar on demand.